Show an ad over header. AMP

I am the second

FDA recommends pausing J&J COVID vaccine after 6 reported cases of blood clots

The U.S. FDA on Tuesday recommended an immediate halt of the use of Johnson & Johnson's COVID-19 vaccine, citing cases of a rare blood clot disorder that six women developed within two weeks of receiving the shot.

Why it matters: The recommendation was issued "out of an abundance of caution" as health officials review data and alternative treatments, but it could risk slowing down the U.S. vaccine rollout.

Keep reading... Show less

Related Articles

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories